SITC Archive Library

SITC 30th Anniversary Annual Meeting (2015): Late Breaking Abstract Session II 

01-30-2017 12:03

SITC 30th Anniversary Annual Meeting (2015): Late Breaking Abstract Session II
November 6-8, 2015
Gaylord National Hotel & Convention Center National Harbor, MD

SITC 30th Anniversary Annual Meeting Organizers
Sandra Demaria, MD – Weill Cornell Medical College
Madhav Dhodapkar, MD – Yale University
Pamela S. Ohashi, PhD – Princess Margaret Cancer Centre
Jennifer A. Wargo, MD – University of Texas MD Anderson Cancer Center
Andrew D. Weinberg, PhD – Earle A. Chiles Research Institute

Program Summary
Late Breaking Abstract Session from the SITC 30th Anniversary Annual Meeting on Saturday, November 7, 2015 in National Harbor, MD.

About the SITC 30th Anniversary Annual Meeting
SITC's 30th Anniversary Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy research. The meeting consisted of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for both structured and informal discussions including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as ongoing SITC projects.

Target Audience
The target audience for this program included basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers that wished to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

#AnnualMeeting #2015 #ClinicalTrials #HeadandNeckCancers #Melanoma #Non-SmallCellLungCancer #ProstateCancer #PresentationSlides #Abstracts #SITC #CombinationTherapy#TherapeuticAntibodies
#AdverseEvents #Clinician #Industry #Oncologist #Researcher

Statistics
0 Favorited
55 Views
2 Files
0 Shares
355 Downloads
Attachment(s)
pdf file
Interim Results of an Ongoing Phase I, Dose Escalation St...   1.09 MB   1 version
Uploaded - 01-30-2017
Meeting: SITC 30th Anniversary Annual Meeting; Session: Late Breaking Abstract Session II; Presentation: Interim Results of an Ongoing Phase I, Dose Escalation Study of MGA271 (Fc-Optimized Humanized Anti-B7-H3 Monoclonal Antibody) in Patients with Refractory B7-H-3-Expressing Neoplasms or Neoplasms whose Vasculature Expresses B7-H3; Presenter: John D. Powderly II, MD, CD1 – Carolina BioOncology Institute, PLLC; Date: November 7, 2015
pdf file
Efficacy of Anti-ICOS Agonist Monoclonal Antibodies in Pr...   754 KB   1 version
Uploaded - 01-30-2017
Meeting: SITC 30th Anniversary Annual Meeting; Session: Late Breaking Abstract Session II; Presentation: Efficacy of Anti-ICOS Agonist Monoclonal Antibodies in Preclinical Tumor Models Provides a Rationale for Clinical Development as Cancer Immunotherapeutics; Presenter: Michael J. Briskin, PhD – Jounce Therapeutics; Date: November 7, 2015